BUFFALO, NY - Efferent Labs is making big strides in the world of biosensors. They've developed a sensor and technique that would allow doctors to see how cells are reacting to treatments in real time using smart devices.

The medical implications of a technology like this are huge. One area where Efferent Labs thinks they could make an impact within the next five years is cancer treatments.

We spoke to Rader in length for the Innovate WNY podcast to learn more about this groundbreaking technology.

Right now Efferent Labs system is in pre-clinical testing and working to miniaturize the sensor. According to Rader the company is on track to meet their goal of being able to roll the product out by 2020.